Brief: Senti Biosciences Regains Compliance With Nasdaq Listing Rule
13/08/2024 22:00
Aug 13 (Reuters) - Senti Biosciences Inc SNTI.O :
* SENTI BIOSCIENCES : ON AUG 2, CO REGAINS COMPLIANCE WITH
NASDAQ
LISTING RULE 5550(A)(2)
Source text for Eikon: ID:n0001854270-24-000099
Further company coverage: SNTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates